In certain individuals, infections can trigger an autoimmune response, resulting in symptoms which mimic various psychiatric and behavioral disorders.
Could symptoms be due to an infection(s) and autoimmune response?

In some individuals, an infection can trigger an abnormal immune response, whereby autoantibodies, intended to fight the infection, mistakenly attack healthy cells in the brain, resulting in the onset of neurologic and/or psychiatric symptoms.

Receiving a proper diagnosis and treatment can dramatically change a patient’s life.

Cunningham Panel Grace’s Story

Grace’s Story

She was suspended from kindergarten and diagnosed with various mental disorders. Her parents spent their life savings searching for answers.

Cunningham Panel Grace’s Story

Julie R.’s Story

At 5 years old he was diagnosed with ADHD, a mood disorder, compulsive behaviors and thoughts, and oppositional disorder. He was prescribed approximately 15 different psychiatric meds over the years.

Cunningham Panel Sunny’s Story

Sunny K.’s Story

In 2nd grade, he developed a strep infection and several illnesses including the flu. Shortly afterwards, he began having tics, emotional lability, anger and rage. He had to be homeschooled.

Cunningham Panel Parker’s Story Part 1

Parker’s Story (Part 1)

At age 10, Parker suddenly developed vocal tics, OCD, psychosis and hallucinations. His mental state was so concerning, he was admitted to a psychiatric hospital. Cunningham Panel™ test results helped clinicians determine appropriate treatments.

Cunningham Panel Parker’s Story Part 2

Parker’s Story (Part 2)

Rare disorder may explain 11-year-old’s sudden odd tics and moodiness (Part 2)

Cunningham Panel Alexias Story

Alexia’s Story

At age 4, Alexia developed a strep throat infection. Within days, she began throwing violent tantrums, was removed from pre-school, started talking about suicide and was admitted to a psychiatric hospital.

B. Robert Mozayeni, MD

Medical and Clinical Advisor

B. Robert Mozayeni MD

Dr. B. Robert Mozayeni was trained in Internal Medicine and Rheumatology at Yale and at NIH. He has had pre- and post-doctoral Fellowships in Molecular Biophysics and Biochemistry at Yale, and also at NIH where he was a Howard Hughes Research Scholar at LMB/DCBD/NCI and later, Senior Staff Fellow at LMMB/NHLBI/NIH. Editorial board of Infectious Diseases – Surveillance, Prevention and Treatment. Past President of the International Lyme and Associated Diseases Society (ILADS).

He is an expert in Translational Medicine, the science and art of advancing medical science safely and efficiently. He is a Fellow of the non-profit Think Lead Innovate Foundation and is a co-founder of the Foundation for the Study of Inflammatory Diseases. He is a Founder of the Foundation for the Study of Inflammatory Diseases to crowd-source medical solutions for complex conditions using existing knowledge, diagnostic methods, and therapies to meet patient needs immediately. He is the Chief Medical Officer of Galaxy Diagnostics, LLC. He is a Board member of the Human-Kind Alliance. Dr. Mozayeni has held admitting privileges (since 1994) on the clinical staff of Suburban Hospital, a member of Johns Hopkins Medicine and an affiliate of the National Institutes of Health Clinical Center.

Safedin Sajo Beqaj, PhD, HCLD, CC (ABB)

Moleculera Labs, Clinical Laboratory Advisor
Medical Database, Inc., President and CEO

Sajo Baqaj, PhD

Dr. Sajo Beqaj is board certified in molecular pathology and genetics and licensed as a Bioanalyst and High Complexity Laboratory Director. He has been practicing as a laboratory director since 2005.

Dr. Beqaj served as a technical director and was part of the initial management team for several well-known laboratories in the clinical lab industry including PathGroup, Nashville, TN; DCL Medical Laboratories, Indianapolis, IN, and Pathology, Inc, Torrance, CA. He is currently serving as off-side CLIA laboratory director for BioCorp Clinical Laboratory, Whittier, CA and Health360 Labs, Garden Grove, CA.

Dr. Beqaj received his Ph.D. in Pathology from Wayne State University Medical School, Detroit, Michigan. He performed his post-doctoral fellowship at Abbott Laboratories from 2001-2003 and with Children’s Hospital and Northwestern University from 2003-2005.

Dr. Beqaj has taught in several academic institutions and has published numerous medical textbook chapters and journal articles. He has served as a principal investigator in clinical trials for several well-known pharmaceutical and diagnostic companies such as Roche HPV Athena, Merck HPV vaccine, BD vaginitis panel, Roche (Vantana) CINtec® Histology clinical trials, and has presented various scientific clinical abstracts and presentations.

He is a member of several medical and scientific associations including the Association of Molecular Pathology, American Association of Clinical Chemistry and the Pan Am Society for Clinical Virology. He has served on a number of clinical laboratory regulatory and scientific committees, and has assisted several laboratories and physicians as a Clinical Laboratory Consultant.